Drug-induced metabolic syndrome
Marion R Wofford1, Deborah S King, T Kristopher Harrell
1Department of Internal Medicine, Division of General Internal Medicine/Hypertension, University of Mississippi Medical Center School of Medicine, Jackson, MS 39216, USA. mwofford@medicine.umsmed.edu
Journal of Clinical Hypertension (Greenwich, Conn.)
|February 14, 2006
Summary
Certain medications can increase the risk of metabolic syndrome, a condition linked to heart disease and type 2 diabetes. Healthcare providers must monitor patients for these risks, especially those with existing risk factors.
Area of Science:
- Endocrinology
- Cardiology
- Pharmacology
Background:
- Metabolic syndrome is a critical risk factor for cardiovascular disease and type 2 diabetes.
- An estimated 24% of US adults had metabolic syndrome between 1988-1994.
- Certain medications are known to elevate metabolic syndrome risk.
Purpose of the Study:
- To highlight the association between specific medications and the development of metabolic syndrome.
- To emphasize the importance of monitoring for metabolic syndrome in patients using at-risk medications.
Main Methods:
- Analysis of epidemiological data (1988-1994) to estimate prevalence.
- Review of pharmacological mechanisms contributing to metabolic syndrome.
- Clinical risk assessment guidelines.
Main Results:
- Medication use can precipitate metabolic syndrome through weight gain or altered metabolism.
- Patients with overweight or other risk factors are particularly vulnerable.
Conclusions:
- Healthcare providers must be vigilant in recognizing medication-induced metabolic syndrome.
- Careful drug selection and patient monitoring are essential for managing cardiovascular and diabetes risks.
Related Concept Videos
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
01:25Diabetic Ketoacidosis l: Introduction
DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...